Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer
Hui Meng, Manman Nan, Yizhen Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16

Showing 16 citing articles:

Application of CRISPR-Cas9 genome editing technology in various fields: A review
Arif Nur Muhammad Ansori, Yulanda Antonius, Raden JK. Susilo, et al.
Narra J (2023) Vol. 3, Iss. 2, pp. e184-e184
Open Access | Times Cited: 34
Strength-Based Therapy: Empowering Athletes' Self-Efficacy and Life Satisfaction
Kamdin Parsakia, Beat Knechtle, Khadijeh Irandoust, et al.
Deleted Journal (2024) Vol. 2, Iss. 2, pp. 1-7
Open Access | Times Cited: 8
From Bench to Bedside: Transforming Cancer Therapy with Protease Inhibitors
Alireza Shoari
Targets (2025) Vol. 3, Iss. 1, pp. 8-8
Open Access
Checkpoint kinase 1 as a promising target in colorectal cancer management
Wenxue Ma, Natalia Baran
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 4
Closed Access
The use of plant-derived exosome-like nanoparticles as a delivery system of CRISPR/Cas9-based therapeutics for editing long non-coding RNAs in cancer colon cells
Tatiana Hillman
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Revitalizing oral cancer research: Crispr-Cas9 technology the promise of genetic editing
S. Sowmya, Dominic Augustine, Shazia Mushtaq, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases
Lanjie Lei, Wenjie Pan, Xin Shou, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines
Małgorzata Adamiec‐Organiściok, Magdalena Wȩgrzyn, Lukasz Cienciala, et al.
Gastroenterology Review (2024) Vol. 19, Iss. 2, pp. 112-120
Open Access | Times Cited: 2
Genome Engineering as a Therapeutic Approach in Cancer Therapy: A Comprehensive Review
Jack Gemayel, Alain Chebly, Hampig Raphaël Kourié, et al.
Advanced Genetics (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1
CRISPR/Cas9-mediated knockout strategies for enhancing immunotherapy in breast cancer
Chenchen Xu
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 11, pp. 8561-8601
Closed Access | Times Cited: 1
Shedding light on the dark genome: Insights into the genetic, CRISPR-based, and pharmacological dependencies of human cancers and disease aggressiveness
Doris Kafita, Panji Nkhoma, Kevin Dzobo, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0296029-e0296029
Open Access | Times Cited: 4
Shedding Light on the Dark Genome: Insights into the Genetic, CRISPR-based, and Pharmacological Dependencies of Human Cancers and Disease Aggressiveness
Doris Kafita, Panji Nkhoma, Kevin Dzobo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Exploring Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-Associated Protein 9 (CRISPR-Cas9) as a Therapeutic Modality for Cancer: A Scoping Review
Abirami Balasubramanian, Keerthana Veluswami, Sudipta Rao, et al.
Cureus (2024)
Open Access
Recent advances in CRISPR-Cas systems for colorectal cancer research and therapeutics
Saeideh Khorshid Sokhangouy, Farzaneh Alizadeh, Malihe Lotfi, et al.
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 8, pp. 677-702
Closed Access
CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance
Zhujun Xu
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 2849-2876
Closed Access | Times Cited: 1
The Potential Therapeutic Applications of CRISPR/Cas9 in Colorectal Cancer
Toktam Sahranavard, Shima Mehrabadi, Ghazaleh Pourali, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 35, pp. 5768-5778
Closed Access
Page 1

Scroll to top